Source: Indian Pharma Post

Fresenius Kabi: Fresenius Kabi & TQ Therapeutics join forces to accelerate cell & gene therapy manufacturing

The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing

Read full article »
Est. Annual Revenue
$5.0-10B
Est. Employees
10-50K
Pierluigi Antonelli's photo - President & CEO of Fresenius Kabi

President & CEO

Pierluigi Antonelli

CEO Approval Rating

- -/100

Read more